Home The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines
Article
Licensed
Unlicensed Requires Authentication

The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines

  • Nalise Low Ah Kee , Ryno J. Naudé , Gregory L. Blatch and Carminita L. Frost EMAIL logo
Published/Copyright: March 1, 2012

Abstract

Cancer procoagulant is present only in malignant tumours and the undifferentiated tissues of human placenta. Its possible role in angiogenesis and metastasis was investigated. Cancer procoagulant increased the steady-state mRNA level of L1 cell adhesion molecule (L1CAM) in MCF-7 breast cancer cells and E14 mouse embryonic stem cells (MESCs), while an increase in angiogenin mRNA was observed in MDA-MB-231 breast cancer cells. Furthermore, production of vascular endothelial growth factor (VEGF) protein in MCF-7 breast cancer cells and E14 MESCs, but decreased in MDA-MB-231 breast cancer cells. We conclude that cancer procoagulant could potentially play a part in angiogenesis in cancer and vascular development during embryonic development.


Corresponding author

Received: 2011-7-4
Accepted: 2011-12-30
Published Online: 2012-03-01
Published in Print: 2012-03-01

©2012 by Walter de Gruyter Berlin Boston

Downloaded on 7.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/hsz-2011-0177/html
Scroll to top button